Tiphaine Lenfant

Tiphaine Lenfant

Auto-generated profile, based on publicly available information

Tiphaine Lenfant

Center for Research in Epidemiology and Statistics, Université Paris Cité and Université Sorbonne Paris Nord, Institut National de la Santé et de la Recherche Médicale, Institut National de la Recherche pour l’Agriculture, l’Alimentation et l’Environnement, Paris, France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2022 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
TLTiphaine Lenfant
Tiphaine Lenfant
ALAnne‐Sophie L'HOnneur
Anne‐Sophie L'HOnneur
BRBrigitte Ranque
Brigitte Ranque
BPBenoît Pilmis
Benoît Pilmis
CCCaroline Charlier
Caroline Charlier
AMAdrien Michon
Adrien Michon
Background: VZV infection can involve every level of the neurologic system: from the central nervous system (CNS) to the peripheral nervous system (PNS), including aseptic meningitis. Prognosis seems to differ between these neurological involvements. Prognostic factors remain unknown.Methods: This is a retrospective multicenter study including all patients with a positive VZV polymerase chain reaction (PCR) in the cerebrospinal fluid (CSF) from eight centers in Paris (France) between 2011 and 2018. Unfavorable outcome was defined as mortality linked to VZV or incomplete recovery. Modified Rankin Scale (mRS) evaluated disability before and after the infection, with the difference designated as Rankin Delta.Results: Seventy‐two patients were included (53% male, median age 51 years, median mRS 0). Immunosuppression was reported in 42%. The clinical spectrum included 26 cases of meningitis, 27 instances of CNS involvement, 16 of PNS involvement, and 3 isolated replications (positive PCR but no criteria for neurological complications from VZV). Antiviral treatment was administered to 69 patients (96%). Sixty‐two patients completed follow‐up. Death linked to VZV occurred in eight cases. Unfavorable outcome (UO) occurred in 60% and was significantly associated with a higher prior mRS (Odd‐ratio (OR) 3.1 [1.4–8.8] p = .012) and the presence of PNS or CNS manifestations (OR 22 [4–181] p = .001, OR 6.2 [1.3–33] p = .03, respectively, compared to meningitis). In the CSF, higher protein level (p < .0001) was also significantly associated with a higher Rankin Delta.Conclusions: Neurological complications of VZV with evidence of CSF viral replication are heterogeneous: aseptic meningitis has a good prognosis, whereas presence of CNS and PNS involvement is associated with a higher risk of mortality and of sequelae, respectively.

1 March 2019 in EBioMedicine
Verified
Journal Article
Open access
PTPauline Trémeaux
Pauline Trémeaux
TLTiphaine Lenfant
Tiphaine Lenfant
FBFaroudy Boufassa
Faroudy Boufassa
AEAsma Essat
Asma Essat
AMAdeline Mélard
Adeline Mélard
VAVéronique Avettand-Fenoel
Véronique Avettand-Fenoel
In the current context of research on HIV reservoirs, offering new insights into the persistence of HIV DNA in infected cells, which prevents viral eradication, may aid in identifying cure strategies. This study aimed to describe the establishment of stable integrated forms among total HIV DNA during primary infection (PHI) and their dynamics during the natural history of infection. Total and integrated HIV DNA were quantified in blood from 74 PHI patients and 97 recent seroconverters (<12 months following infection, "progression cohort"). The evolution of both markers over six years was modelled (mixed-effect linear models). Their predictive values for disease progression were studied (Cox models). For most patients during PHI, stable integrated forms were a minority among total HIV DNA (median: 12%) and became predominant thereafter (median at AIDS stage: 100%). Both total and integrated HIV DNA increased over a six-year period. Patients from the progression cohort who reached clinical AIDS during follow-up (n = 34) exhibited higher total and integrated HIV DNA levels at seroconversion and a higher percentage of integrated forms than did slower progressors (n = 63) (median: 100% vs 44%). The integrated HIV DNA load was strongly associated with the risk of developing AIDS (aRR = 2.63, p = 0.002). The profile of "rapid" or "slower" progression in the natural history of HIV infection appears to be determined early in the course of HIV infection. The strong predominance of unstable unintegrated forms in PHI may explain the great benefit of this early treatment, which induces a sharp decrease in total HIV DNA. FUND: French National Agency for Research on AIDS and Viral Hepatitis.

19 December 2023 in BMJ
Verified
Journal Article
Open access
PDF file
TLTiphaine Lenfant
Tiphaine Lenfant
PRPhilippe Ravaud
Philippe Ravaud
VMVictor M. Montori
Victor M. Montori
GBGro R. Berntsen
Gro R. Berntsen
VTViet-Thi Tran
Viet-Thi Tran
Experts predict that no society or healthcare system will be able to sustainably care for patients with chronic conditions in the next 20 years. 1 Similarly, healthcare is increasingly unsustainable for patients, overwhelmed by the work of accessing and using healthcare services and enacting self-care routines.


15 July 2022 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
LJLina Jeantin
Lina Jeantin
TLTiphaine Lenfant
Tiphaine Lenfant
PBPierre Bataille
Pierre Bataille
HBHubert de Boysson
Hubert de Boysson
PCPascal Cathébras
Pascal Cathébras
PCPierre Charles
Pierre Charles
Objective: While myocardial impairment is a predictor of poor prognosis in antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV), little is known about valvular involvement. This study aims at describing the clinical presentation, management, and outcome of endocarditis associated with AAV.Methods: We conducted a multicenter retrospective study in centers affiliated with the French Vasculitis Study Group. We included patients with granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), or eosinophilic GPA with endocardial impairment. A systematic review was then performed through PubMed, Embase, and Cochrane Library from inception up to September 2020.Results: The retrospective cohort included 9 patients (82%) with GPA, 1 (9%) with MPA, and 1 (9%) with unclassified AAV. Clinical presentation included acute valvular insufficiency (n = 7, 64%), cardiac failure (n = 3, 27%), dyspnea (n = 3, 27%), and no symptoms (n = 2, 18%). The aortic valve was the most frequently affected (n = 8/10, 80%), and vegetations were noted in 4 of 10 patients (40%). Six patients (55%) underwent surgical valvular replacement. No death from endocarditis was reported. The systematic review retrieved 42 patients from 40 references: 30 (71%) had GPA, 21 (50%) presented with vegetations, the aortic valve (n = 26, 62%) was the most frequently involved. Valvular replacement was required in 20 cases (48%) and 5 patients (13%) died from the endocarditic impairment.Conclusion: Endocarditis is a rare and potentially life-threatening manifestation of AAV. Acute valvular insufficiency may lead to urgent surgery. Implementing transthoracic echocardiography in standard assessment at baseline and follow-up of AAV might reduce the delay to diagnosis and allow earlier immunosuppressive treatment before surgery is needed.

2 February 2026 in JAMA Network Open
Verified
Journal Article
Open access
TLTiphaine Lenfant
Tiphaine Lenfant
EPElodie Perrodeau
Elodie Perrodeau
PRPhilippe Ravaud
Philippe Ravaud
VTViet-Thi Tran
Viet-Thi Tran
Importance: As health care systems face greater strain due to the increasing prevalence of long-term conditions (LTCs) and workforce shortages, optimizing remote care could help maintain access to timely follow-up care while alleviating pressure on in-person services. Objectives: To assess the availability and use of 3 remote modalities by patients with LTCs for interacting with their referring physician; their preference for in-person vs remote consultation for different situations; and their willingness to trade an in-person consultation with their referring physician in 20 days for an earlier remote consultation with a nonreferring physician. Design, Setting, and Participants: This survey study was conducted from April 1 to August 28, 2024, in France. Adult patients with at least 1 LTC participating in a nationwide e-cohort were recruited to complete an online survey. To obtain estimates representative of patients with LTCs in France, analyses were performed on a weighted dataset with calibration on margins from the 2021 Santé Publique France Survey. Exposures: Each patient was presented with 1 of 5 randomly assigned situations regarding worsening symptoms, new symptoms, annual checkup, medication renewal, and results discussion. Main Outcomes and Measures: Responses were assessed for (1) availability and use of remote modalities (video consultation, telephone contact, and asynchronous message exchange) for interacting with the referring physician; (2) patient preference for in-person or remote modalities when interacting with the referring physician depending on the situation; and (3) patient willingness to trade an in-person consultation with their physician in 20 days for an earlier direct-to-consumer (DTC) remote consultation with a nonreferring physician. Results: Among 1995 participants (mean [SD] age, 55 [17] years; 56% women), 47% reported that no remote modalities for communicating with their referring physician were available. (All percentages presented are weighted.) Up to 55% preferred remote over in-person consultation to interact with their referring physician, with higher proportions for results discussion (43%) and medication renewal (55%) than for worsening symptoms (36%), new symptoms (25%), and annual checkup (26%). Up to 51% of patients were willing to trade an in-person consultation with their referring physician in 20 days for a DTC remote consultation within 5 days with a nonreferring physician. Conclusions and Relevance: This survey study showed that patients with LTCs had limited access to remote modalities to interact with their referring physician for follow-up care, and patients considered replacing an in-person with a remote consultation even with another physician depending on the situation and the length of delay. Further research is needed to investigate the effective integration of remote care into the health care system in ways that maintain patient-centered care and improve patient outcomes.